These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4729848)

  • 1. Control of procainamide therapy after cardiac infarction.
    Royds R; Shaw TR; Kumana CR; Padgham D; Hamer J
    Br Heart J; 1973 Aug; 35(8):862-3. PubMed ID: 4729848
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic procainamide.
    Koch-Weser J
    N Engl J Med; 1970 Mar; 282(10):569. PubMed ID: 5413110
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylactic procainamide.
    Yarnall SR
    N Engl J Med; 1970 Mar; 282(10):568-9. PubMed ID: 5413109
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Talbot RG; Dolder M; Prescott L; Julian DG
    Br Heart J; 1975 Jul; 37(7):779. PubMed ID: 1156488
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    J Maine Med Assoc; 1974 Jun; 65(6):143-4 passim. PubMed ID: 4845852
    [No Abstract]   [Full Text] [Related]  

  • 7. Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.
    Ihlen H; Ditlefsen L
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):720-6. PubMed ID: 812650
    [No Abstract]   [Full Text] [Related]  

  • 8. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H; Skomedal T; Stafsnes H; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):257-62. PubMed ID: 805020
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term use of procaine amide following acute myocardial infarction.
    Kosowsky BD; Taylor J; Lown B; Ritchie RF
    Circulation; 1973 Jun; 47(6):1204-10. PubMed ID: 4122729
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic procainamide.
    Koch-Weser J
    N Engl J Med; 1970 Mar; 282(10):569-70. PubMed ID: 5413112
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic procainamide.
    Bete JM
    N Engl J Med; 1970 Mar; 282(10):569. PubMed ID: 5413111
    [No Abstract]   [Full Text] [Related]  

  • 13. Dysrhythmia prophylaxis.
    Killip T
    N Engl J Med; 1969 Dec; 281(23):1304-5. PubMed ID: 5349809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J
    Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 17. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of rhythm disorders in acute myocardial infarct].
    Djordjevic BS; Bozinovic L
    Actual Cardiol Angeiol Int (Paris); 1966; 15(2):109-11. PubMed ID: 5927070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.